Skip to main content
Premium Trial:

Request an Annual Quote

GEUVADIS Consortium Seeks to Standardize Clinical Sequencing Efforts


Investigators at 17 institutions across Europe and the US have banded together in an effort to establish standards for human genome sequencing practice and analysis. The Genetic European Variation in Disease, or GEUVADIS, consortium is coordinated by Xavier Estivill at the Center for Genomic Regulation in Barcelona, and is funded for a period of 36 months by the European Commission under its Seventh Framework Programme.

GEUVADIS aims to establish standards for quality control and sequence data assessment; develop models for data storage, exchange, and access; standardize biological and medical sequence data interpretation, handling, and analysis; establish ethical standards related to sequence variation-based phenotype prediction; and develop effective dissemination and training forums and protocols.

Estivill, who leads the Genetic Causes of Disease group at CRG, is hopeful that GEUVADIS will serve as "a strong European framework that can be used to dissect the genetics of disease and to implement genomics responsibly in the medical setting," he says in a statement.

GEUVADIS also aims to develop efficient forums to exchange medical information as well as any technological insights its members generate in pursuit of their specific objectives. To that end, Estivill approached Johns Hopkins University School of Medicine's Ada Hamosh — the scientific director of the Online Mendelian Inheritance in Man database — in November 2009 to ask that she join the consortium.

OMIM "is the main database for descriptions of Mendelian disorders and traits and the genes responsible" and is "queried daily by over 1,000 unique users," Hamosh says. OMIM "will help with dissemination of this information to the biomedical community as new discoveries are made" through the GEUVADIS consortium's efforts, she adds.

Though Hamosh says that OMIM is currently "based exclusively on the biomedical future," her team is now "adapting to meet the expected onslaught of new data from this and other efforts around the world."

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.